and/or aims): The long term objective of this proposal is to determine the role of the Src family of tyrosine kinases in the regulatory process of malignant transformation. The P.I. has demonstrated that the specific activity of Src is elevated in most malignant and pre-malignant lesions of the colon. Moreover, Src activity decreases as the intestinal crypt cells differentiate. These results suggest that upregulation of Src is important for growth and transformation of intestinal cells. The overall goal of the proposal is to define the molecular mechanisms that downregulate Src in normal intestine, and those that upregulate Src in colon cancer. Thus, the hypothesis to be tested is related to specific domains of Src and the proteins that bind to them, are important regulators of kinase activity. Thus, the current overall effort is directed toward identifying cellular proteins that modulate Src function during intestinal maturation and malignant transformation.
One specific aim i s to identify and characterize proteins that interact with the unique, SH3 and/or SH2 domains of Src and human colon carcinoma cells, normal intestine and fibroblasts. Three strategies will be utilized to answer the specific aims. These are mainly: 1) lambda gt11 expression library screening 2) the yeast two-hybrid system, and 3) recombinant GST fusion proteins. The site and Src required for binding to an interacting protein would be determined, mutations will be introduced into the binding site and the functional consequences on Src activity will be assessed. The PI has demonstrated that one Src-binding protein is the Syp tyrosine phosphatase. Syp appears to dephosphorylate Src at Tyr 527, and the transforming F527 Src mutant phosphorylates Syp on tyrosine. Both events are known mechanisms to upregulate enzymatic activity. The second specific aim is to extend these studies and examine the functional consequences of the Src-Syp interaction. The sequences on both Src and Syp required for binding and the tyrosine on Syp phosphorylated by F527 Src will be identified, mutations will be introduced into these sites and the functional consequences on enzymatic activity will be assessed. These studies are likely to yield important information regarding the functional aspects of Src as they relate to human colon cancer.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043743-10
Application #
6176609
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Hamilton, Frank A
Project Start
1991-06-15
Project End
2001-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
10
Fiscal Year
2000
Total Cost
$223,773
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Cheng, Zhuan-Fen; Pai, Reetesh K; Cartwright, Christine A (2018) Rack1 function in intestinal epithelia: regulating crypt cell proliferation and regeneration and promoting differentiation and apoptosis. Am J Physiol Gastrointest Liver Physiol 314:G1-G13
Cheng, Zhuan-Fen; Cartwright, Christine A (2018) Rack1 maintains intestinal homeostasis by protecting the integrity of the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 314:G263-G274
Swaminathan, G; Cartwright, C A (2012) Rack1 promotes epithelial cell-cell adhesion by regulating E-cadherin endocytosis. Oncogene 31:376-89
Mamidipudi, V; Cartwright, C A (2009) A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways. Oncogene 28:4421-33
Mamidipudi, Vidya; Miller, Laura D; Mochly-Rosen, Daria et al. (2007) Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cells. Biochem Biophys Res Commun 352:423-30
Miller, Laura D; Lee, Kelly C; Mochly-Rosen, Daria et al. (2004) RACK1 regulates Src-mediated Sam68 and p190RhoGAP signaling. Oncogene 23:5682-6
Mamidipudi, Vidya; Chang, Betty Y; Harte, Rachel A et al. (2004) RACK1 inhibits the serum- and anchorage-independent growth of v-Src transformed cells. FEBS Lett 567:321-6
Chang, Betty Y; Cartwright, Christine A (2003) Detection of protein kinase-binding partners by the yeast two-hybrid analysis. Methods Mol Biol 233:327-43
Chang, Betty Y; Harte, Rachel A; Cartwright, Christine A (2002) RACK1: a novel substrate for the Src protein-tyrosine kinase. Oncogene 21:7619-29
Chang, B Y; Chiang, M; Cartwright, C A (2001) The interaction of Src and RACK1 is enhanced by activation of protein kinase C and tyrosine phosphorylation of RACK1. J Biol Chem 276:20346-56

Showing the most recent 10 out of 12 publications